Topaloglu H. Expensive molecular therapies for rare genetic disorders: carrier detection or newborn screening should be the strategy. A personal opinion. JICNA [Internet]. 2021 Dec. 11 [cited 2024 Nov. 21];1(1). Available from: https://jicna.org/index.php/journal/article/view/225